Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Dec 01, 2010 (Vol. 30, No. 21)

PNNL Biological MS Data and Software Distribution Center

URL:omics.pnl.gov
  • Large number of free software downloads, nicely organized site
  • Most of the software only runs with Microsoft Windows

In the current climate of fierce competition among laboratories for funding and publications, it is refreshing whenever I come across websites dedicated to the dissemination of data and analysis tools. Such is the case with the Pacific Northwest National Laboratory’s Biological MS Data and Software Distribution Center (what a mouthful!). On this site, visitors can browse (either by publication, organism, creation date, or instrument used) the mass spectrometry data generated by the laboratory and subsequently download the data files. Alternatively, visitors (at least, those with a PC) can take advantage of the free-to-download proteomics software, which includes MS/MS analysis tools, data-analysis and data-presentation tools, and MS data file utilities, among others. There are approximately 50 software downloads in all.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »